Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2

Nature Cell Biology

Volumn 14, Issue 11, 2012, Pages 1212-1222

  Chakrabarti, Rumela ^a,b   Hwang, Julie ^a   Andres Blanco, Mario ^a   Wei, Yong ^a   Lukačišin, Martin ^a   Romano, Rose Anne ^b   Smalley, Kirsten ^b   Liu, Song ^c   Yang, Qifeng ^d,e,g   Ibrahim, Toni ^f   Mercatali, Laura ^f   Amadori, Dino ^f   Haffty, Bruce G ^d,e   Sinha, Satrajit ^b   Kang, Yibin ^a,e,h  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^f DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^g Department of Breast Surgery ^*  (United States)

^h SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN CDH2; PROTEIN FN1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 5; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; TRANSCRIPTION FACTOR TWIST2; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST METASTASIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPRESSOR GENE; SNAIL2 GENE; TRANSCRIPTION REGULATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS;

EID: 84869045299     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2607     Document Type: Article

References (65)

1. Thiery, J.P. & Sleeman, J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142 (2006 (Pubitemid 43278296)
2. Yang, J. & Weinberg, R.A. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829 (2008 (Pubitemid 351757205)
3. Lee, J.M., Dedhar, S., Kalluri, R. & Thompson, E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172, 973-981 (2006
4. Thiery, J.P., Acloque, H., Huang, R.Y. & Nieto, M.A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009
5. Acloque, H. et al. Reciprocal repression between Sox3 and snail transcription factors de-nes embryonic territories at gastrulation. Dev. Cell 21, 546-558 (2011
6. Nieto, M.A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Ann. Rev. Cell Dev. Biol. 27, 347-376 (2011
7. Thompson, E.W. & Williams, E.D. EMT and MET in carcinoma-clinical observations, regulatory pathways and new models. Clin. Exp. Meta. 25, 591-592 (2008
8. Thiery, J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454 (2002
9. Polyak, K. & Weinberg, R.A. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273 (2009
10. Gregory, P.A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601 (2008 (Pubitemid 351627379)
11. Park, S.M., Gaur, A.B., Lengyel, E. & Peter, M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (2008 (Pubitemid 351482843)
12. Korpal, M., Lee, E.S., Hu, G. & Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910-14914 (2008
13. Burk, U. et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582-589 (2008 (Pubitemid 351772923)
14. Medici, D., Hay, E.D. & Olsen, B.R. Snail and Slug promote epithelial-mesenchymal transition through -catenin-T-cell factor-4-dependent expression of transforming growth factor-3. Mol. Biol. Cell 19, 4875-4887 (2008
15. Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11, 1487-1495 (2009
16. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (2004 (Pubitemid 38798858)
17. Cano, A. et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76-83 (2000
18. Liu, Y.N. et al. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene (2012
19. Liu, Y.N. et al. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor -initiated prostate cancer epithelial-mesenchymal transition. Mol. Cell. Biol. 32, 941-953 (2012
20. Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015-1028 (2012
21. Mani, S.A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008 (Pubitemid 351636299)
22. Sharrocks, A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2, 827-837 (2001 (Pubitemid 33674083)
23. Hollenhorst, P.C., McIntosh, L.P. & Graves, B.J. Genomic and biochemical insights into the speci-city of ETS transcription factors. Ann. Rev. Biochem. 80, 437-471 (2011
24. Desmaze, C. et al. Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors. Cancer Genet. Cytogenet. 97, 12-19 (1997 (Pubitemid 27318471)
25. Dittmer, J. & Nordheim, A. Ets transcription factors and human disease. Biochim. Biophys. Acta 1377, F1-F11 (1998
26. Peter, M. et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14, 1159-1164 (1997 (Pubitemid 27141917)
27. Sharrocks, A.D., Brown, A.L., Ling, Y. & Yates, P.R. The ETS-domain transcription factor family. Int. J. Biochem. Cell Biol. 29, 1371-1387 (1997 (Pubitemid 28153488)
28. Oikawa, T. & Yamada, T. Molecular biology of the Ets family of transcription factors. Gene 303, 11-34 (2003 (Pubitemid 36151767)
29. Sapi, E., Flick, M.B., Rodov, S. & Kacinski, B.M. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Res. 58, 1027-1033 (1998 (Pubitemid 28182474)
30. Sementchenko, V.I., Schweinfest, C.W., Papas, T.S. & Watson, D.K. ETS2 function is required to maintain the transformed state of human prostate cancer cells. Oncogene 17, 2883-2888 (1998
31. Feldman, R.J., Sementchenko, V.I., Gayed, M., Fraig, M.M. & Watson, D.K. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 63, 4626-4631 (2003 (Pubitemid 36951040)
32. Zhou, J. et al. A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines. Oncogene 17, 2719-2732 (1998 (Pubitemid 28554231)
33. Ma, X.J. et al. Gene expression pro-les of human breast cancer progression. Proc. Natl Acad. Sci. USA 100, 5974-5979 (2003
34. Zhou, J. et al. Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. EMBO J. 24, 635-644 (2005 (Pubitemid 40343264)
35. Oakes, S.R. et al. The Ets transcription factor Elf5 speci-es mammary alveolar cell fate. Genes Dev. 22, 581-586 (2008 (Pubitemid 351342431)
36. Choi, Y.S., Chakrabarti, R., Escamilla-Hernandez, R. & Sinha, S. Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. Dev. Biol. 329, 227-241 (2009
37. Chakrabarti, R. et al. Elf5 regulates mammary gland stem/progenitor cell fate by in-uencing notch signaling. Stem Cells 30, 1496-1508 (2012
38. Herschkowitz, J.I. et al. Identi-cation of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Gen. Biol. 8, R76 (2007
39. Gupta, P.B. et al. Identi-cation of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645-659 (2009
40. Taube, J.H. et al. Core epithelial-to-mesenchymal transition interactome gene- expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl Acad. Sci. USA 107, 15449-15454 (2010
41. Blick, T. et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J. Mammary Gland Biol. Neoplasia 15, 235-252 (2010
42. Hoe-ich, K.P. et al. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clin. Cancer Res. 15, 4649-4664 (2009
43. Nouhi, Z. et al. De-ning the role of prolactin as an invasion suppressor hormone in breast cancer cells. Cancer Res. 66, 1824-1832 (2006 (Pubitemid 43259969)
44. Escamilla-Hernandez, R. et al. Genome-wide search identi-es Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. BMC Mol. Biol. 11, 68 (2010
45. Casas, E. et al. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 71, 245-254 (2011
46. Turashvili, G. et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7, 55 (2007
47. Lee, S. et al. Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am. J. Pathol. 171, 252-262 (2007 (Pubitemid 47339242)
48. Van de Vijver, M.J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J Med. 347, 1999-2009 (2002 (Pubitemid 35461656)
49. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treatment 123, 725-731 (2010
50. Minn, A.J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524 (2005 (Pubitemid 41112921)
51. DeNardo, D.G. et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91-102 (2009
52. Kaplan, R.N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005 (Pubitemid 41753060)
53. Miller, F.R., Miller, B.E. & Heppner, G.H. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Inv. Metastasis 3, 22-31 (1983 (Pubitemid 13083351)
54. Guy, C.T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl Acad. Sci. USA 89, 10578-10582 (1992
55. Valastyan, S. & Weinberg, R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292 (2011
56. Sethi, N. & Kang, Y. Dysregulation of developmental pathways in bone metastasis. Bone 48, 16-22 (2011
57. Lim, E. et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 12, R21 (2010
58. Nieto, M.A. The snail superfamily of zinc-nger transcription factors. Nat. Rev. Mol. Cell Biol. 3, 155-166 (2002
59. Martin, T.A., Goyal, A., Watkins, G. & Jiang, W.G. Expression of the transcription factors snail, slug, and twist and their clinical signi-cance in human breast cancer. Ann. Surg. Oncol. 12, 488-496 (2005 (Pubitemid 40884264)
60. Proia, T.A. et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell. Stem Cell 8, 149-163 (2011
61. Battula, V.L. et al. Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 28, 1435-1445 (2010
62. Lu, X. et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging -4-1-positive osteoclast progenitors. Cancer Cell 20, 701-714 (2011
63. Mootha, V.K. et al. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115, 629-640 (2003 (Pubitemid 37508523)
64. Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression pro-les. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005 (Pubitemid 41528093)
65. Naylor, M.J. et al. Ablation of -1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J. Cell Biol. 171, 717-728 (2005 (Pubitemid 41668730)